Micofenolato mofetile (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Micofenolato mofetile" in Italian language version.

refsWebsite

Global rank Italian rank

13nih.gov

4^th place

9^th place

8oadoi.org

799^th place

22^nd place

8doi.org

2^nd place

7^th place

1drugbank.ca

4,294^th place

low place

1fda.gov

447^th place

644^th place

doi.org

dx.doi.org

Moore RA, Derry S, Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis, in Arthritis Research & Therapy, vol. 8, n. 6, 2006, pp. R182, DOI:10.1186/ar2093, PMID 17163990, , PMC 1794528.
D'Cruz DP, Khamashta MA, Hughes GR, Systemic lupus erythematosus, in Lancet, vol. 369, n. 9561, febbraio 2007, pp. 587–96, DOI:10.1016/S0140-6736(07)60279-7, PMID 17307106.
Walsh M, James M, Jayne D, Tonelli M, Manns BJ, Hemmelgarn BR, Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis, in Clinical Journal of the American Society of Nephrology, vol. 2, n. 5, settembre 2007, pp. 968–75, DOI:10.2215/CJN.01200307, PMID 17702723.
Knight SR, Russell NK, Barcena L, Morris PJ, Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review, in Transplantation, vol. 87, n. 6, marzo 2009, pp. 785–94, DOI:10.1097/TP.0b013e3181952623, PMID 19300178.
Remuzzi G, Lesti M, Gotti E, et al., Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial, in Lancet, vol. 364, n. 9433, 2004, pp. 503–12, DOI:10.1016/S0140-6736(04)16808-6, PMID 15302193.
Mimouni D, Anhalt GJ, Cummins DL, Kouba DJ, Thorne JE, Nousari HC, Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil, in Archives of Dermatology, vol. 139, n. 6, giugno 2003, pp. 739–42, DOI:10.1001/archderm.139.6.739, PMID 12810504.
Diamond MS, Zachariah M, Harris E, Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA, in Virology, vol. 304, n. 2, 2002, pp. 211–21, DOI:10.1006/viro.2002.1685, PMID 12504563.
Takhampunya R, Ubol S, Houng HS, Cameron CE, Padmanabhan R, Inhibition of dengue virus replication by mycophenolic acid and ribavirin, in The Journal of General Virology, vol. 87, Pt 7, luglio 2006, pp. 1947–52, DOI:10.1099/vir.0.81655-0, PMID 16760396.

drugbank.ca

DrugBank: Mycophenolate mofetil (DB00688)

fda.gov

CellCept (mycophenolate mofetil) August 2009, su fda.gov, U.S. Food and Drug Administration, 14 agosto 2009. URL consultato il 7 aprile 2011.

nih.gov

ncbi.nlm.nih.gov

Moore RA, Derry S, Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis, in Arthritis Research & Therapy, vol. 8, n. 6, 2006, pp. R182, DOI:10.1186/ar2093, PMID 17163990, , PMC 1794528.
GE Norby, Lerang K, Holdaas H, Gran JT, Strøm EH, Draganov B, Os I, Hartmann A, Gilboe IM, [Lupus-nephritis--diagnosis and treatment], in Tidsskr Nor Laegeforen, vol. 3, 130(11), giugno 2010, pp. 1140-4, PMID 20531500.
Houssiau FA, D'Cruz D, Sangle S, Remy P, Vasconcelos C, Petrovic R, Fiehn C, de Ramon Garrido E, Gilboe IM, Tektonidou M, Blockmans D, Ravelingien I, le Guern V, Depresseux G, Guillevin L, Cervera R; the MAINTAIN Nephritis Trial Group, Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial, in Ann Rheum Dis, ottobre 2010, PMID 20833738.
D'Cruz DP, Khamashta MA, Hughes GR, Systemic lupus erythematosus, in Lancet, vol. 369, n. 9561, febbraio 2007, pp. 587–96, DOI:10.1016/S0140-6736(07)60279-7, PMID 17307106.
Walsh M, James M, Jayne D, Tonelli M, Manns BJ, Hemmelgarn BR, Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis, in Clinical Journal of the American Society of Nephrology, vol. 2, n. 5, settembre 2007, pp. 968–75, DOI:10.2215/CJN.01200307, PMID 17702723.
Koukoulaki M, Goumenos DS, The accumulated experience with the use of mycophenolate mofetil in primary glomerulonephritis. Review, in Expert Opin Investig Drugs, vol. 5, n. 19, maggio 2010, pp. 673-87, PMID 20374037.
Knight SR, Russell NK, Barcena L, Morris PJ, Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review, in Transplantation, vol. 87, n. 6, marzo 2009, pp. 785–94, DOI:10.1097/TP.0b013e3181952623, PMID 19300178.
Remuzzi G, Lesti M, Gotti E, et al., Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial, in Lancet, vol. 364, n. 9433, 2004, pp. 503–12, DOI:10.1016/S0140-6736(04)16808-6, PMID 15302193.
Mimouni D, Anhalt GJ, Cummins DL, Kouba DJ, Thorne JE, Nousari HC, Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil, in Archives of Dermatology, vol. 139, n. 6, giugno 2003, pp. 739–42, DOI:10.1001/archderm.139.6.739, PMID 12810504.
Diamond MS, Zachariah M, Harris E, Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA, in Virology, vol. 304, n. 2, 2002, pp. 211–21, DOI:10.1006/viro.2002.1685, PMID 12504563.
Takhampunya R, Ubol S, Houng HS, Cameron CE, Padmanabhan R, Inhibition of dengue virus replication by mycophenolic acid and ribavirin, in The Journal of General Virology, vol. 87, Pt 7, luglio 2006, pp. 1947–52, DOI:10.1099/vir.0.81655-0, PMID 16760396.
Marcén R., Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection. Review, in Drugs, vol. 12, 69(16), novembre 2009, pp. 2227-43, PMID 19852526.

pubmedcentral.nih.gov

Moore RA, Derry S, Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis, in Arthritis Research & Therapy, vol. 8, n. 6, 2006, pp. R182, DOI:10.1186/ar2093, PMID 17163990, , PMC 1794528.

oadoi.org

Moore RA, Derry S, Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis, in Arthritis Research & Therapy, vol. 8, n. 6, 2006, pp. R182, DOI:10.1186/ar2093, PMID 17163990, , PMC 1794528.
D'Cruz DP, Khamashta MA, Hughes GR, Systemic lupus erythematosus, in Lancet, vol. 369, n. 9561, febbraio 2007, pp. 587–96, DOI:10.1016/S0140-6736(07)60279-7, PMID 17307106.
Walsh M, James M, Jayne D, Tonelli M, Manns BJ, Hemmelgarn BR, Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis, in Clinical Journal of the American Society of Nephrology, vol. 2, n. 5, settembre 2007, pp. 968–75, DOI:10.2215/CJN.01200307, PMID 17702723.
Knight SR, Russell NK, Barcena L, Morris PJ, Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review, in Transplantation, vol. 87, n. 6, marzo 2009, pp. 785–94, DOI:10.1097/TP.0b013e3181952623, PMID 19300178.
Remuzzi G, Lesti M, Gotti E, et al., Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial, in Lancet, vol. 364, n. 9433, 2004, pp. 503–12, DOI:10.1016/S0140-6736(04)16808-6, PMID 15302193.
Mimouni D, Anhalt GJ, Cummins DL, Kouba DJ, Thorne JE, Nousari HC, Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil, in Archives of Dermatology, vol. 139, n. 6, giugno 2003, pp. 739–42, DOI:10.1001/archderm.139.6.739, PMID 12810504.
Diamond MS, Zachariah M, Harris E, Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA, in Virology, vol. 304, n. 2, 2002, pp. 211–21, DOI:10.1006/viro.2002.1685, PMID 12504563.
Takhampunya R, Ubol S, Houng HS, Cameron CE, Padmanabhan R, Inhibition of dengue virus replication by mycophenolic acid and ribavirin, in The Journal of General Virology, vol. 87, Pt 7, luglio 2006, pp. 1947–52, DOI:10.1099/vir.0.81655-0, PMID 16760396.